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background:  A family history of atrial fibrillation (AF) is associated with a higher incidence of AF in relatives. We compared clinical 
characteristics and AF-related processes of care in AF patients by family history of AF.
Methods:   Using the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF), we compared those with and without a family 
history of AF. A family history of AF was defined as AF in a first-degree family member and obtained by patient self-reporting. Multivariable 
Cox proportional hazard analyses were performed to estimate the comparative risk of progression of AF (paroxysmal to/or persistent to 
permanent) and incidence of stroke or non-central nervous system (CNS) embolism or trans ischemic attack (TIA) during the study period.
results:  Among 9,999 AF-patients from 176 US outpatient clinics; 1,481 (14.8%) had a family history of AF. Relative to those without, 
those with a family history were younger and had more severe AF-related symptoms, were more likely treated with rhythm control and 
had lower median CHA2DS2-VASc risk scores (Table). The risk of AF progression (adjusted HR 0.98, 95% CI 0.85-1.14) and incidence of 
stroke or non-CNS embolism or TIA (adjusted HR 0.95, 95% CI 0.67-1.34) did not differ between the two groups.
Conclusion:  While patients with a family history of AF were younger, had more severe symptoms, and were more likely to receive rhythm 
control strategies than those without a family history, they had similar rates of AF progression and thromboembolism.
Table 1: Baseline Characteristics
No Family History of Atrial Fibrillation
(N=8518)
Family History of Atrial Fibrillation
(N=1481) P-value
Median age in years (IQR) 75 (67-82) 72 (63-79) <.0001
Women, % 41.9 44.8 0.0371
Race, white, % 88.8 90.8 0.0887
Comorbidities, %
Hypertension 83.1 81.8 0.2153
Diabetes 29.7 27.5 0.0900
Congestive heart failure 32.4 30.2 0.2455
Type of AF, %
First Detected / New Onset 4.8 4.5 0.9478
Paroxysmal AF 50.8 50.8
Persistent AF 16.7 16.8
Permanent AF 27.8 28.0
EHRA score (symptom score), %
No Symptoms 39.1 31.6 <.0001
Mild 44.9 48.2
Severe 14.2 17.5
Disabling 1.7 2.6
Medication, %
Currently taking warfarin 71.2 70.8 0.7188
Currently in antithrombotic
therapy 44.3 41.3 0.0328
Median CHA2DS2-VASc Risk Score (IQR) 4 (3-5) 4 (2-5) <.0001
